Comerica Bank’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-82,024
| Closed | -$64.8K | – | 3724 |
|
|
2025
Q1 | $64.8K | Buy |
82,024
+81,877
| +55,699% | +$64.7K | ﹤0.01% | 2722 |
|
|
2024
Q4 | $243 | Buy |
+147
| New | +$243 | ﹤0.01% | 3635 |
|
|
2024
Q2 | – | Sell |
-879
| Closed | -$6.45K | – | 3738 |
|
|
2024
Q1 | $6.45K | Buy |
879
+350
| +66% | +$2.57K | ﹤0.01% | 3278 |
|
|
2023
Q4 | $1.98K | Buy |
+529
| New | +$1.98K | ﹤0.01% | 3525 |
|
|
2022
Q4 | $765K | Buy |
133,760
+10,320
| +8% | +$59K | 0.01% | 1602 |
|
|
2022
Q3 | $2.33M | Sell |
123,440
-34,890
| -22% | -$660K | 0.02% | 955 |
|
|
2022
Q2 | $5.15M | Buy |
158,330
+50,779
| +47% | +$1.65M | 0.04% | 519 |
|
|
2022
Q1 | $3.94M | Buy |
+107,551
| New | +$3.94M | 0.03% | 717 |
|
|
2021
Q1 | – | Sell |
-2,363
| Closed | -$230K | – | 2342 |
|
|
2020
Q4 | $230K | Buy |
+2,363
| New | +$230K | ﹤0.01% | 2209 |
|